Clinical Trial Update: DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating switching to a fixed-dose combination of doravirine/lamivudine/tenofovir disoproxil fumarate in people with controlle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DELSTRIGO (DORAVIRINE, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: University Hospital, Caen | Conditions: Hiv | Phase 2 | Status: RECRUITING